Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
37 Cards in this Set
- Front
- Back
In blood clot formation, what is the purpose of vasoconstriction? How is it mediated?
|
Vasoconstriction: momentarily stops blood loss
Endoth cells release ENDOTHELIN Platelets release THROMBOXANE A2 both of these are vasoconstrictors |
|
What is it about endothelial cell injury that induces platelet adhesion? What receptors are required?
|
Injury exposes SUBENDOTHELIAL MATRIX (collagen)
GpIb Receptor on platelet and vonWillebrand factor on subendothelium (BRIDGE) |
|
Defect in VW factor?
|
VW Dz
|
|
Defect in GpIb?
|
Bernard Soulier Syndrome
|
|
What do platelets do when activated to recruit more platelets?
What enzyme is activated? What chemical does this produce? |
Undergo shape change and release reaction (via open canalicular system)
Activates Phospholipase A2 (AA-->PGG2-->THROMBOXANE A2) Thromboxane A2 not only vasoconstricts, but also is a platelet agonist (aggregation) |
|
How do endothelial cells moderate platelet aggregation and vasoconstriction? Describe the reaction.
|
Phosphopliase-->AA-->PGG2-->PROSTACYCLIN
Prostacylin inhibits plateley aggregation and induces vasodilation |
|
How does the mechanism of Cox-1 inhibitors differ from that of Cox-2 inhibitors?
|
Cox-1 inhibitors inhibits platelet aggregation (required to produce PGG2 which makes Thromboxane A2)
Cox-2 inhibitors inhibit PGG2 formation in ENDOTHELIAL CELLS which inhibit Prostacyclin formation and decreases inhibition of platelet aggregation (pro-thrombic effect) |
|
Cox-2 inhibitor suffix?
|
-coxib
|
|
What receptors and bridges are required for platelet aggregation?
|
Act'd platelets express GpIIb/IIIa receptor
Liver increases fibrinogen production FIBRINOGEN serves as bridge |
|
GpIIb/IIIa receptor defect?
|
Glanzmann's Thrombasthenia
|
|
Effect of GpIIb/IIIa inhibitor?
|
potent anticoagulant
|
|
What is primary hemostasis? What steps are involved?
|
Formation of unstable platelet plug.
Involves vasoconstriction, platelet adhseion, shape change, release rxn, aggregation |
|
What is petechiae?
|
microhemorrhages (spontaneous), show up as small red spots on skin
due to thrombocytopenia!!! |
|
What is purpura?
|
When petechiae coalesce (larger blood spots)
|
|
What does bleeding time measure?
|
Measure primary hemostasis, i.e., formation of an unstable platelet plug
|
|
What is the purpose of fibrin?
Describe the extrinsic and intrinsic pathways leading to its formation. |
Fibrin is end product of coagulation cascade; necessary for formation of stable blood clot
Extrinsic PW: Tissue Factor released from damaged endoth cell Factor 7 Intrinsic: Factor 12 (Hageman) Factor 11, 9, 8 Both of these lead to COMMON PW: Factor 10, 5, Ca2+, Phospholipase Prothrombin (Factor 2) to Thrombin (2a) Fibrinogen to Fibrin |
|
Describe the cross-talk between the extrinsic and intrinsic pathways.
|
Factor 7 of EPW can activate Factor 9 on IPW
|
|
Factor 12 deficiencies result in?
|
Thrombosis! (not bleeding disorders; it's not the only factor of clotting)
|
|
Hemophilia A vs Hemophilia B (factor deficiencies)
|
Hemo A: Factor 9 deficiency
Hemo B: Factor 8 deficiency |
|
Tests to assess EPW and IPW of coaguln cascade. Names and how they differ.
|
EPW: Prothrombin Time (PT) - time from add'n of tissue factor to formn of clot; aka INR
IPW: Partial Thromboplastin Time (PTT) add contact activating substance (for XII-->XIIa) to clot |
|
Fibrinogen-->Fibrin requires?
|
THROMBIN
Factor 13 (Fibrin stabilizing factor) Calcium |
|
Effect of hemophilia on bleeding time?
|
NO effect. bleeding time measures unstable platelet plug formation time.
|
|
Effect of liver disease on clotting?
Vitamin K deficiency? Why? |
Liver dz: no clotting factors
Vit K: Factors 2, 7, 9, 10 require Vit K for post-translnl activn |
|
Mechanism of warfarin sodium (Coumadin)
|
inhibits oxidation of vitamin K (blocks post-translnl mods of vit K)
NOTE: not a total block, just a decrease |
|
What does plasminogen-->plasmin require? Role of plasmin?
|
Requires PLASMINOGEN ACTIVATORS
Plasmin chews up fibrin |
|
What are the two subtypes of plasminogen activators? How do they differ?
|
Urokinase-like PA: activates plasminogen in fluid phase
Tissue-Type PA: in endothelial cells Both activate plasminogen on surface of fibrin |
|
Role of alpha2-antiplasmin?
|
Inactivates free plasmin in blood
|
|
Streptokinase is an example of what?
|
Therapeutic Plasminogen Activator
TPA's are expressed by ENDOTHELIAL CELLS |
|
What would overwhelming stimulus to the coagulation cascade result in?
|
Consumptive coagulopathy-->bleeding due to decreased clotting factors, decreased platelets, increased fibrinolysis
|
|
Role of Antithrobmic Factor III?
|
Inhibits Factors 12, 11, 10, 9, and thrombin
ACCELERATED by HEPARIN ON ENDOTHELIAL CELLS |
|
Role of thrombomodulin?
|
Present on endothelial cells, when thrombin binds, activates PROTEIN C
Prot S is a co-factor of PROT C Act'd PROT C (APC) degrades Factors 8, 5 |
|
How do uninjured endothelial cells prevent platelet aggregation?
|
Secrete PGI2 and NO (potent vasodilators and inhibitors of platelet aggregation)
|
|
What are two ways the endothelial cells promote coagulation?
|
1) If injured, release Tissue Factor (initiates blood coaguln cascade)
2) Binding sites for Factors 9 and 10; augments their activity |
|
How does arterial thrombosis arise? Consequences? Fates of the thrombi?
|
Turbulent flow due to arterial narrowing
Platelets and leuks contact abnormal surface (no shearing forces), initiates PLATELET AGGREGATION and formation MURAL THROMBUS Fates: Act as nidus (nest) Incorp'd into cell wall EMBOLIZE!! |
|
Red vs White Infarct
|
Red (Hemorrhagic): due to venous occlusion in area with single venous outflow (testis, ovary), loose tissues (lungs), areas with dual circuln (lung, sm intest) when FLOW RE-ESTABLISHED
White (pale) infarct: ARTERIAL occlusion in solid tissue (heart, spleen, kidney) where hemorrhage is limited |
|
How does venous thrombosis arise? Fates?
|
Small deposits (commonly in valve cusp pockets), form nidus, grow in direcn of flow, occlude lumen; slow flow
Fates: Lysis (resoln) Organizn (new capillary channels formed, aka RECANALIZATION) Embolization |
|
What is hypercoaguability? 2 causes?
|
Spontaneous thromboses in pts under 50
Mutation in Factor 5 (Leiden) gene-->APC resistance (decreased inactivation of Factor 5) Mutation in protrhombin gene (Hereditary resistance to Prot C; a natural anticoagulant) |